Heinz Ludwig

机构：Wilhelminen Hospital · ORCID：0000-0002-3302-8726

发表论文 735 篇 · 总被引 50777 次 · h-index 104

代表论文

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network (2023 · The Lancet Oncology · 被引 202)
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel (2023 · Blood Cancer Journal · 被引 201)
EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma (2025 · Nature Reviews Clinical Oncology · 被引 157)
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group (2023 · The Lancet Oncology · 被引 146)
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN) (2023 · Leukemia · 被引 49)
CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1 (2023 · Leukemia · 被引 24)